Improving anti-angiogenic therapy via selective delivery of cationic liposomes to tumour vasculature

Author： Dass C.R.  

Publisher： Elsevier

ISSN： 0378-5173

Source： International Journal of Pharmaceutics, Vol.267, Iss.1, 2003-11, pp. : 1-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic tumour therapy: will it work?

By Augustin H.G.  

Trends in Pharmacological Sciences, Vol. 19, Iss. 6, 1998-06 ,pp. : 216-222

Elsevier

Access to resources Recommend Favorite

Anti-angiogenic therapy of proliferative diabetic retinopathy

By Danis R.P.   Ciulla T.A.   Criswell M.   Pratt L.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 395-407

Informa Healthcare

Access to resources Recommend Favorite

Rhinitis and epistaxis in patients treated by anti-angiogenic therapy

By Prulière-Escabasse V.   Escudier E.   Balheda R.   Soria J.   Coste A.   Massard C.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 285-286

Springer Publishing Company

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite